DK0925060T3 - Hurtigt nedbrydende pellets - Google Patents

Hurtigt nedbrydende pellets

Info

Publication number
DK0925060T3
DK0925060T3 DK97943848T DK97943848T DK0925060T3 DK 0925060 T3 DK0925060 T3 DK 0925060T3 DK 97943848 T DK97943848 T DK 97943848T DK 97943848 T DK97943848 T DK 97943848T DK 0925060 T3 DK0925060 T3 DK 0925060T3
Authority
DK
Denmark
Prior art keywords
pellets
rapidly degrading
degrading
rapidly
degrading pellets
Prior art date
Application number
DK97943848T
Other languages
English (en)
Inventor
Michaela Opitz
Bueren Hendrik Von
Rolf-Dieter Gabel
Geoffrey Lee
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7805374&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0925060(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of DK0925060T3 publication Critical patent/DK0925060T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/20—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by expressing the material, e.g. through sieves and fragmenting the extruded length
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97943848T 1996-09-12 1997-09-09 Hurtigt nedbrydende pellets DK0925060T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19637082A DE19637082A1 (de) 1996-09-12 1996-09-12 Schnellzerfallende Pellets
PCT/EP1997/004897 WO1998010754A1 (de) 1996-09-12 1997-09-09 Schnellzerfallende pellets

Publications (1)

Publication Number Publication Date
DK0925060T3 true DK0925060T3 (da) 2003-04-07

Family

ID=7805374

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97943848T DK0925060T3 (da) 1996-09-12 1997-09-09 Hurtigt nedbrydende pellets

Country Status (18)

Country Link
US (2) US6224909B1 (da)
EP (1) EP0925060B2 (da)
JP (1) JP2001513752A (da)
KR (1) KR100514467B1 (da)
CN (1) CN1146409C (da)
AR (1) AR012829A1 (da)
AT (1) ATE228830T1 (da)
AU (1) AU730673B2 (da)
BR (1) BR9713199A (da)
CA (1) CA2265766C (da)
DE (2) DE19637082A1 (da)
DK (1) DK0925060T3 (da)
ES (1) ES2187822T5 (da)
PT (1) PT925060E (da)
TR (1) TR199901147T2 (da)
TW (1) TW508250B (da)
WO (1) WO1998010754A1 (da)
ZA (1) ZA978171B (da)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136028A0 (en) * 1997-11-12 2001-05-20 Boehringer Mannheim Pharm Corp Novel oral dosage form for carvedilol
JP2001522796A (ja) * 1997-11-12 2001-11-20 ザ ダウ ケミカル カンパニー 易流動性で、無塵の、冷水分散可能な食用薄塗組成物
US20020054911A1 (en) * 2000-05-11 2002-05-09 Boehringer Mannheim Pharmaceutical Corporation-Sm Ithkline Beckman Corporation, Limited Partnershi Novel oral dosage form for carvedilol
US6852337B2 (en) * 1998-04-09 2005-02-08 Roche Diagnostics Gmbh Carvedilol-galenics
EP0968714A1 (de) * 1998-07-02 2000-01-05 Roche Diagnostics GmbH Verfahren zur Herstellung schnellauflösender pharmazeutischer Zubereitungen von schwerlöslichen Wirkstoffen
AU3522399A (en) * 1998-04-09 1999-11-01 Roche Diagnostics Gmbh Carvedilol-galenics
PE20001302A1 (es) * 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
ES2200811T3 (es) * 1999-01-12 2004-03-16 MERCK SHARP & DOHME LIMITED Sistema autoemulgente esferonizado para agentes hidrofobos y sensibles al agua.
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
DE19930795A1 (de) * 1999-07-03 2001-01-11 Encapbiosystems Ag Schiers Verfahren zur Verkapselung von Substanzen sowie Teilchen dafür
CO5200844A1 (es) * 1999-09-17 2002-09-27 Novartis Ag Una combinacion que comprende nateglinida y cuando por menos otro compuesto antidiabetico usada para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con dibetes
US6113915A (en) 1999-10-12 2000-09-05 Allergan Sales, Inc. Methods for treating pain
US6420473B1 (en) * 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
GT200100039A (es) * 2000-03-16 2001-12-31 Pfizer Inhibidor de la glucogeno fosforilasa.
AU2001263813A1 (en) * 2000-04-03 2001-10-15 F.Hoffmann-La Roche Ag Concentrated solutions of carvedilol
US20010036959A1 (en) * 2000-04-03 2001-11-01 Gabel Rolf Dieter Carvedilol-hydrophilic solutions
WO2001078725A2 (en) * 2000-04-13 2001-10-25 Synthon B.V. Modified release formulations containing a hypnotic agent
WO2002065834A2 (en) * 2000-10-24 2002-08-29 Smithkline Beecham Corporation Novel formulations of carvedilol
AU2256702A (en) 2000-12-01 2002-06-11 Kyowa Hakko Kogyo Kk Composition improved in solubility or oral absorbability
EP1275377B1 (en) * 2001-07-11 2003-06-18 Apr Applied Pharma Research S.A. Granulates containing liposoluble substances and process of preparation thereof
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
WO2003028645A2 (en) * 2001-10-01 2003-04-10 Smithkline Beecham Corporation Novel compositions of carvedilol
SE0103369D0 (sv) * 2001-10-09 2001-10-09 Astrazeneca Ab Pharmaceutical formulation
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
EP1448169A1 (en) * 2001-11-07 2004-08-25 Fujisawa Pharmaceutical Co., Ltd. Method for improving dissolution of poorly dispersible medicaments
EP1469829B1 (en) * 2002-02-01 2016-01-27 Bend Research, Inc Immediate release dosage forms containing solid drug dispersions
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
JP2006518380A (ja) 2003-01-31 2006-08-10 スミスクライン・ビーチャム・コーポレイション 固体分散体組成物
US7182738B2 (en) * 2003-04-23 2007-02-27 Marctec, Llc Patient monitoring apparatus and method for orthosis and other devices
DK2821067T3 (da) 2003-09-12 2017-12-04 Amgen Inc Hurtigopløsningsformulering af cinacalcet
EP1686967A4 (en) * 2003-11-25 2012-08-08 Smithkline Beecham Cork Ltd CARVEDILOL-FREE BASE, SALTS, WATER-FREE FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULAS AND TREATMENT OR DISPOSAL PROCEDURES
EP1691789B1 (en) * 2003-11-25 2017-12-20 SmithKline Beecham (Cork) Limited Carvedilol free base, salts, anhydrous forms or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
GB0329851D0 (en) * 2003-12-23 2004-01-28 Temrel Inc Process for producing particles for pharmaceutical compositions
RU2382634C2 (ru) * 2003-12-23 2010-02-27 Темрел Лимитед Способ получения пилюль для фармацевтических композиций
ES2244324B1 (es) * 2004-03-25 2006-11-16 Ferrer Internacional, S.A. Composiciones diureticas de liberacion prolongada.
CA2569961A1 (en) * 2004-06-10 2005-12-29 Glatt Air Techniques, Inc Controlled release pharmaceutical formulation
US9000040B2 (en) * 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
EP1811933B1 (en) 2004-09-28 2016-03-23 Atrium Medical Corporation Barrier layer
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
DE102005004893B4 (de) * 2005-02-03 2011-02-10 Dow Global Technologies Inc., Midland Verfahren zur Formgebung von Celluloseethern
JP5004236B2 (ja) * 2005-02-09 2012-08-22 キッセイ薬品工業株式会社 口腔内崩壊錠
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
BRPI0620236A2 (pt) * 2005-12-23 2011-11-01 Lek Pharmaceuticals péletes dilacerantes
US20190083399A9 (en) * 2006-04-03 2019-03-21 Isa Odidi Drug delivery composition
EP2043613A1 (en) * 2006-07-14 2009-04-08 Fmc Corporation Solid form
WO2008070072A2 (en) * 2006-12-01 2008-06-12 Mutual Pharmaceutical Company, Inc. Carvedilol forms, compositions, and methods of preparation thereof
US20090028935A1 (en) * 2006-12-01 2009-01-29 Kristin Arnold Carvedilol forms, compositions, and methods of preparation thereof
BRPI0810025A2 (pt) * 2007-04-19 2014-10-14 Disphar Int Bv Formulação farmacêutica oral de liberação imediata, método para preparar uma formulação farmacêutica multiparticulada, e, uso de ácido ursodesoxicólico
CN101980702B (zh) * 2008-03-28 2013-01-02 琳得科株式会社 口服制剂
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
TWI415604B (zh) * 2009-09-29 2013-11-21 Tsh Biopharm Corp Ltd 調控釋放卡菲蒂羅劑型
JP5870023B2 (ja) * 2010-02-22 2016-02-24 第一三共株式会社 経口用徐放性固形製剤
EP2540294B1 (en) * 2010-02-22 2016-08-03 Daiichi Sankyo Company, Limited Sustained-release solid preparation for oral use
WO2011102504A1 (ja) * 2010-02-22 2011-08-25 第一三共株式会社 経口用徐放性固形製剤
EP2544667B1 (en) * 2010-03-09 2018-11-14 Alkermes Pharma Ireland Limited Alcohol resistant enteric pharmaceutical compositions
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
JP5578534B2 (ja) * 2010-12-27 2014-08-27 富田製薬株式会社 製剤用崩壊型核粒子
DE112011105038T5 (de) 2011-03-14 2013-12-12 Hewlett-Packard Development Co., L.P. Vorrichtung, System und Verfahren mit fortlaufender Tintenversorgung
CA2885680C (en) 2011-09-07 2022-10-04 Roland Saur-Brosch Formulation for the controlled release of one or several substances in the digestive tract of a mammal.
CN104768552A (zh) 2012-09-03 2015-07-08 第一三共株式会社 含有盐酸氢吗啡酮的口服持续释放药物组合物
KR102158339B1 (ko) * 2016-02-05 2020-09-21 삼진제약주식회사 인습성이 개선된 카르베딜롤 속방성 제제
CA3029842A1 (en) 2016-07-19 2018-01-25 Exact Sciences Development Company, Llc Methylated control dna
CN108421497A (zh) * 2018-04-03 2018-08-21 杨高品 药物连续化制粒的生产工艺和设备
WO2024231554A1 (en) * 2023-05-11 2024-11-14 Catalent U.K. Swindon Zydis Limited Increasing permeation for pre-gastric absorption of active pharmaceutical ingredients

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3532692A1 (de) 1985-09-13 1987-03-19 Boehringer Mannheim Gmbh Verfahren zum herstellen von tabletten aus pellets
US5258185A (en) * 1989-08-23 1993-11-02 Bauer Kurt H Highly active, rapidly absorbable formulations of glibenclamide, processes for the production thereof and their use
PH27186A (en) * 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
CA2085231C (en) 1990-07-02 1997-12-30 Berthold Stemmle Process for the preparation of shaped, compressed controlled-release unit-dosage forms, and the compressed unit-dosage forms thus obtained
US5464632C1 (en) 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
TW355683B (en) * 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
DE4413350A1 (de) 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
MX9600857A (es) * 1994-07-08 1997-06-28 Astra Ab Forma de dosificacion i en tabletas, con unidades multiples.
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation

Also Published As

Publication number Publication date
TR199901147T2 (xx) 1999-07-21
US6224909B1 (en) 2001-05-01
TW508250B (en) 2002-11-01
WO1998010754A1 (de) 1998-03-19
CA2265766A1 (en) 1998-03-19
ES2187822T3 (es) 2003-06-16
US6379706B2 (en) 2002-04-30
EP0925060B2 (de) 2010-06-16
CA2265766C (en) 2006-04-25
CN1146409C (zh) 2004-04-21
JP2001513752A (ja) 2001-09-04
DE59708898D1 (de) 2003-01-16
EP0925060B1 (de) 2002-12-04
PT925060E (pt) 2003-04-30
DE19637082A1 (de) 1998-03-19
KR20000036013A (ko) 2000-06-26
ZA978171B (en) 1999-03-11
CN1237104A (zh) 1999-12-01
ATE228830T1 (de) 2002-12-15
BR9713199A (pt) 2000-04-04
AU730673B2 (en) 2001-03-08
ES2187822T5 (es) 2010-10-28
AU4553997A (en) 1998-04-02
EP0925060A1 (de) 1999-06-30
KR100514467B1 (ko) 2005-09-15
US20010004458A1 (en) 2001-06-21
AR012829A1 (es) 2000-11-22

Similar Documents

Publication Publication Date Title
DK0925060T3 (da) Hurtigt nedbrydende pellets
NO985499D0 (no) Likestr°mstransformator/reaktor
BR9708316A (pt) Aglomerados
ATE262512T1 (de) Arylalkanoylpyridazine
ID18010A (id) Oligosakarida termodifikasi
DE69726895D1 (de) Ballenpresse
ATE208773T1 (de) Chinoxalindione
FI965003L (fi) Pelletit
DE69731046D1 (de) Sicherheitsbehälter
DE59706650D1 (de) Ballenpresse
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
KR980000769U (ko) 병상
DK0932494T3 (da) Pillepresse
DE69716384D1 (de) Granularer hydratisierungswirkstoff
ID16910A (id) Asetilena biaril-asetilena biaril sebagai penghambat-penghambat matriks metaloproteasa-matriks metaloproteasa
DE69725503D1 (de) Ballenpresse
DE69737452D1 (de) Ballenpresse
NO984043D0 (no) Ensileringsmiddel
DE59701309D1 (de) Kopfbedeckung
KR980004490U (ko) 화살
SE9603687D0 (sv) Pelletsmatare
KR970048711U (ko) 개집
KR970048683U (ko) 사료초 채취기
ITMI960684U3 (it) Reattore gravitazionale-centripeto
FI2469U1 (fi) Pellettipoltin